Lv52
1268 积分 2025-05-06 加入
The present and future of bispecific antibodies for cancer therapy
29天前
已完结
Stochasticity in cancer immunotherapy stems from rare but functionally critical Spark T cells
2个月前
已完结
Regulatory T Cell Depletion in Cancer: Challenges, Opportunities, and Future Directions for Antibody Development
4个月前
已完结
Epigenetic regulation of T cell exhaustion in cancer
5个月前
已完结
Expression of chimeric monomer and dimer proteins on the plasma membrane of mammalian cells
5个月前
已完结
Generating functionally stable and antigen-specific Treg cells from effector T cells for cell therapy of inflammatory diseases
5个月前
已完结
Targeting Tregs in T1DM: bridging heterogeneity, mechanisms, and clinical progress
6个月前
已关闭
Up-regulated PLA2G10 in cancer impairs T cell infiltration to dampen immunity
6个月前
已完结
PD-L1 and the dawn of modern cancer immunotherapy
6个月前
已完结
The evolving immuno-angiogenic paradigm in NSCLC: lessons from ivonescimab
6个月前
已完结
皖公网安备34019202002308
